A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function

NCT05610657 ·Status: COMPLETED ·Phase: PHASE1

STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT

NCT04604496 ·Status: COMPLETED ·Phase: PHASE1

A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT

NCT04193436 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

NCT05835180 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function

NCT00956306 ·Status: COMPLETED ·Phase: PHASE1

PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers

NCT02121860 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Emraclidine

NCT05935033 ·Status: COMPLETED ·Phase: PHASE1

KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment

NCT04166942 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031)

NCT01767688 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers

NCT03072056 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study of Abiraterone Acetate in Patients With Severe Hepatic Impairment Compared to Patients With Normal Hepatic Function

NCT01516047 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

NCT06888115 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Miricorilant

NCT05553470 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

NCT02101190 ·Status: COMPLETED ·Phase: PHASE1

Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)

NCT03306667 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod

NCT04639115 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function

NCT00418626 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic Function

NCT04056468 ·Status: COMPLETED ·Phase: PHASE1

Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite

NCT04190654 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment

NCT04587622 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)

NCT01465412 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Sitravatinib

NCT04772612 ·Status: COMPLETED ·Phase: PHASE1

Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients

NCT03765671 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment

NCT01594957 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

NCT04293029 ·Status: COMPLETED ·Phase: PHASE1